1. Abu-Elmagd, K.M., Fung, J., Draviam, R., Shannon, W., Jain, A., Alessiani, M., Takaya, S., Venkataramanan, R., Warty V.S., Tzakis, A., Todo, S. and Starzl, T.E. (1991): Four-hour versus 24-hour intravenous infusion of FK 506 in liver transplantation. Transplant. Proc., 23, 2767-2770.
2. Alloway, R., Steinberg, S., Khalil, K., Gourishankar, S., Miller, J., Norman, D., Hariharan, S., Pirsch, J., Matas, A., Zaltzman, J., Wisemandle, K., Fitzsimmons, W. and First, M.R. (2005): Conversion of stable kidney transplant recipients from a twice daily Prograf-based regimen to a once daily modified release tacrolimus-based regimen. Transplant. Proc., 37, 867-870.
3. Dansirikul, C., Staatz, C.E., Duffull, S.B., Taylor, P.J., Lynch, S.V. and Tett, S.E. (2006): Relationships of tacrolimus pharmacokinetic measures and adverse outcomes in stable adult liver transplant recipients. J. Clin. Pharm. Ther., 31, 17-25.
4. Didlake, R.H., Dreyfus, K., Kerman, R.H., Van Buren, C.T. and Kahan, B.D. (1988): Patient noncompliance: a major cause of late graft failure in cyclosporine-treated renal transplants. Transplant. Proc., 20, 63-69.
5. Fennell, R.S., Foulkes, L.M. and Boggs, S.R. (1994): Family-based program to promote medication compliance in renal transplant children. Transplant. Proc., 26, 102-103.